Literature DB >> 2777047

Effect of Roux-en-Y biliary diversion on Campylobacter pylori.

H J O'Connor1, K M Newbold, J Alexander-Williams, H Thompson, J Drumm, I A Donovan.   

Abstract

To assess the effect of biliary diversion on gastric colonization by Campylobacter pylori, we undertook a retrospective histologic study of 24 patients with symptomatic bile reflux after peptic ulcer surgery, who had endoscopic gastric biopsies performed before and after a Roux-en-Y operation. The time interval between the preoperative and postoperative endoscopic examinations ranged from 0.8 to 9.8 yr (mean 4.7 yr). The partial gastrectomy specimen, which had been resected at the initial operation, was available for assessment in 12 patients (50%). Biopsy specimens were assessed for the presence of C. pylori and scored for severity of reflux gastritis by the use of a histologic grading system. Ten of the 12 partial gastrectomy specimens (83%) were C. pylori-positive. Only 13 of the 24 patients (54%) were C. pylori-positive before the Roux-en-Y operation, rising to 22 (92%) after biliary diversion (p = 0.008). The median reflux score was 6 in the partial gastrectomy specimens; it rose to 11 before the Roux-en-Y operation and fell again to 6 after biliary diversion (p less than 0.001). These results suggest that C. pylori may recolonize the gastric remnant after biliary diversion.

Entities:  

Mesh:

Year:  1989        PMID: 2777047     DOI: 10.1016/0016-5085(89)91504-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  14 in total

1.  Helicobacter pylori and surgery. Bile reflux is important in eradicating Helicobacter pylori.

Authors:  D Karat; S M Griffin
Journal:  BMJ       Date:  1998-09-05

2.  Helicobacter pylori infection in Meckel's diverticula.

Authors:  K M Newbold; H J O'Connor
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

3.  Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.

Authors:  Jae Jin Hwang; Dong Ho Lee; Kyu Keun Kang; Ae-Ra Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 4.  Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.

Authors:  Ken-ichi Mukaisho; Tadashi Hagiwara; Takahisa Nakayama; Takanori Hattori; Hiroyuki Sugihara
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  Primary duodenogastric reflux in children and adolescents.

Authors:  Dominique Hermans; Etienne-Marc Sokal; Jean-Marie Collard; Renato Romagnoli; Jean-Paul Buts
Journal:  Eur J Pediatr       Date:  2003-06-26       Impact factor: 3.183

6.  Helicobacter pylori infection increases following cholecystectomy.

Authors:  M T Caldwell; M McDermott; S Jazrawi; G O'Dowd; P J Byrne; T N Walsh; D O Hourihane; T P Hennessy
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

7.  Behavior of the infection by Helicobacter pylori of the gastric remnant after subtotal gastrectomy and Roux-en-Y anastomosis for benign diseases.

Authors:  Attila Csendes; Gladys Smok; Ana María Burgos
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

8.  Helicobacter pylori requires an acidic environment to survive in the presence of urea.

Authors:  M Clyne; A Labigne; B Drumm
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Helicobacter pylori and luminal gastric pH. Relationships in nonulcer dyspepsia.

Authors:  P Bechi; R Dei; A Amorosi; G Marcuzzo; C Cortesini
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 10.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.